DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Boston Convention and Exhibition Center

2013年6月23日 (日) 午前 8:30 - 2013年6月27日 (木) 午後 12:45

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

EU Update: PROTECT and EnCePP

Session Chair(s)

Stella  Blackburn, MD, MA, MSC, FFPM, FISPE, FRCP

Stella Blackburn, MD, MA, MSC, FFPM, FISPE, FRCP

Strategy

Consultant, United Kingdom

Triage Strategies for Screening Longitudinal Observational Databases

Learning Objective : Discuss the multi-disciplinary approach adopted by the EMA to improve the BR assessment of medicines;Identify the core principles of scientific excellence, independence and transparency introduced by EU regulators and academic community for the conduct of postauthorization studies on safety and BR;Describe the main methods for BR integration and visualization and how they perform in real life case studies.

Speaker(s)

Diana  Hughes, MD

Benefit-risk Integration and Representation: Results From PROTECT

Diana Hughes, MD

Pfizer Inc, United States

Vice President, Worldwide Safety

Niklas  Noren, PHD, MSC

Triage Strategies for Screening Longitudinal Observational Databases

Niklas Noren, PHD, MSC

Uppsala Monitoring Centre (UMC) , Sweden

Chief Science Officer

Stella  Blackburn, MD, MA, MSC, FFPM, FISPE, FRCP

ENCePP: Strengthening Methodology, Transparency and Independence

Stella Blackburn, MD, MA, MSC, FFPM, FISPE, FRCP

Consultant, United Kingdom

Strategy

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。